210 related articles for article (PubMed ID: 20693817)
1. Intravitreal triamcinolone.
Tao Y; Jonas JB
Ophthalmologica; 2011; 225(1):1-20. PubMed ID: 20693817
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
3. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
5. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
Jonas JB; Schlichtenbrede F
Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257
[TBL] [Abstract][Full Text] [Related]
6. [Complications of intravitreal injections--own experience].
Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Jonas JB; Kreissig I; Degenring R
Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
10. Complications of intravitreal steroid injections.
Reichle ML
Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
[TBL] [Abstract][Full Text] [Related]
11. Drug safety evaluation of intravitreal triamcinolone acetonide.
Veritti D; Di Giulio A; Sarao V; Lanzetta P
Expert Opin Drug Saf; 2012 Mar; 11(2):331-40. PubMed ID: 22066820
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
13. The use of intravitreal corticosteroids, evidence-based and otherwise.
Conti SM; Kertes PJ
Curr Opin Ophthalmol; 2006 Jun; 17(3):235-44. PubMed ID: 16794435
[TBL] [Abstract][Full Text] [Related]
14. Short-term complications of intravitreal injection of triamcinolone acetonide.
Roth DB; Realini T; Feuer WJ; Radhakrishnan R; Gloth J; Heimmel MR; Fechtner RD; Yarian DL; Green SN
Retina; 2008 Jan; 28(1):66-70. PubMed ID: 18185140
[TBL] [Abstract][Full Text] [Related]
15. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
17. Re: Triamcinolone acetonide in ocular therapeutics.
Rishi P; Sharma T; Rishi E
Surv Ophthalmol; 2008; 53(2):184; author reply 184. PubMed ID: 18348883
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
Elbendary AM; Shahin MM
Retina; 2011 Nov; 31(10):2058-64. PubMed ID: 21765371
[TBL] [Abstract][Full Text] [Related]
20. Ocular morbidity associated with intravitreal triamcinolone acetonide.
Konstantopoulos A; Williams CP; Newsom RS; Luff AJ
Eye (Lond); 2007 Mar; 21(3):317-20. PubMed ID: 16710433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]